BioVie (BIVI) Stock: Buy, Sell, or Hold?
$1.19
-0.07 (-5.56%)
▼
5d:
-1.65%
30d:
+2.59%
90d:
-15.0%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (53%)
Quality Score
38/100
Position
OVERSOLD
30-Day Fair Range
$1.21 – $1.44
Position: OVERSOLD
Forward P/E & Valuation
-1.9x
Next 12M consensus est.
Wall Street Target
$5.26
+341.6% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$1.11 / $2.66
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: BIVI shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When BIVI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: BIVI is currently trading at $1.19, which is considered oversold relative to its 30-day fair value range of $1.21 to $1.44.
Technical Outlook: Technically, BIVI is in a downtrend. Immediate support is located at $1.10, while resistance sits at $2.66. Short-term momentum is weak, with the stock down 5.6% recently.
Market Sentiment: BIVI scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $5.25 (+341.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BIVI is in a downtrend. Immediate support is located at $1.10, while resistance sits at $2.66. Short-term momentum is weak, with the stock down 5.6% recently.
Market Sentiment: BIVI scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $5.25 (+341.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.21 -
$1.44
Company Quality Score
38/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
52.6%
Trading Range & Key Levels
30-Day Trading Range
$1.21 -
$1.44
Current vs Trading Range
OVERSOLD
Support Level
$1.11
Resistance Level
$2.66
Current Trend
Downtrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.6%)
- BULLISH: Trading 341.6% below Wall St target ($5.25)
- WARNING: Composite score 38/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-1.89
Wall Street Target
$5.26
(+341.6%)
Share BIVI Analysis
Share this live BIVI analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (BIVI)
Bearish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 11, 2026
Daily AI digest
AI Retail Discussion Summary:
BioVie is presenting additional data on its Parkinson's disease drug Bezisterim at the AD PD2027 International Conference.
Key Retail Themes:
Drug development
Clinical trials
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 9:51 PM ET
Data refreshes hourly during market hours. Next update: 10:51 PM
Data refreshes hourly during market hours. Next update: 10:51 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BIVI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RVMD
Revolution Medicines Inc |
STRONG BUY
25 analysts |
$261 | 38 SELL |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
21 analysts |
$95 | 41 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$86 | 46 HOLD |
|
JANX
Janux Therapeutics Inc |
STRONG BUY
18 analysts |
$32 | 42 HOLD |
|
SNDX
Syndax Pharmaceuticals I… |
STRONG BUY
12 analysts |
$35 | 58 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive BIVI Research Pages
